TARA ABERNATHY: Open Payments
NPI 1194066712 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$270 in 15 payments from 7 companies in 2025. Trend: 2023 $13 · 2024 $284 · 2025 $270
Food & beverage: $270
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $104 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| Verona Pharma, Inc. | 1 | $28 |
| Novo Nordisk Inc | 1 | $25 |
| Dexcom, Inc. | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 2 | $19 |
| Esperion Therapeutics, Inc. | 1 | $17 |
Products named: SHINGRIX, UBRELVY, VRAYLAR, Ohtuvayre, Ozempic, Dexcom G6 Transmitter, QULIPTA, VOQUEZNA.
Industry payments across TN — which companies pay providers there.
